Search results

How expensive and time consuming are your tests for optimising your catalyst?

Four international authorities will deliver plenary addresses virtually at the 15th International Conference on Accelerator Mass Spectrometry (AMS15) , which will be held online from 15-19 November.

ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

Research indicates that the portable x-ray fluorescence (XRF) is an appropriate analytical technique for determining seafood provenance at external sites.

ANSTO has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99 (Mo-99), with less enrichment of uranium-235 (U-235) and produce less waste. 

A team of researchers including the University of Rochester, CSIRO and ANSTO has found methane emissions from human fossil sources have been greatly underestimated.

$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

Applications are now being accepted for the Industry foundations Scholarship.

Multi-faceted approach to dating Australian Indigenous rock art from Kimberley region

ANSTO has made two public submissions to parliamentary inquiries with another to be submitted in February 2020 on matters relating to nuclear technologies, their peaceful applications, and the nuclear fuel cycle.

New facility will greatly enhance Australia’s capability in stress engineering for industry